RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ROSSI D
Collezione ASL Città di Torino

Items : 19

Extremely Long-Lasting B-cell Depletion and BAFFling Effects Following Obinutuzumab-Based Regimen in Lupus Nephritis. in Kidney international reports / Kidney Int Rep. 2024 Aug 10;9(10):3079-3080. doi: 10.1016/j.ekir.2024.08.008. eCollection 2024 Oct.

2024
ASL Città di Torino

Roccatello D; Sciascia S; De Simone E; Schindler T; Martins E; Mao HA; Rossi D; Fenoglio R;

The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study. in Nutrients / Nutrients. 2024 Nov 29;16(23):4132. doi: 10.3390/nu16234132.

2024
ASL Città di Torino

Sciascia S; Ferrara G; Roccatello L; Rubini E; Foddai SG; Radin M; Cecchi I; Rossi D; Barinotti A; Ricceri F; Gilcrease W; Baldovino S; Ferreira Poshar A; Conti A; Fenoglio R;

Fitwalking: A New Frontier for Kidney Patients - A Center's Experience. in Kidney & blood pressure research / Kidney Blood Press Res. 2024;49(1):443-456. doi: 10.1159/000539525. Epub 2024 May 28.

2024
ASL Città di Torino

Pozzato M; Parodi G; Rossi D; Stasi E; Roccatello D;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.

2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.

2023
ASL Città di Torino

Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D; Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.

2023
ASL Città di Torino

Roccatello D; Fenoglio R; Caniggia I; Kamgaing J; Naretto C; Cecchi I; Rubini E; Rossi D; De Simone E; Del Vecchio G; Cozzi M; Sciascia S;

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.

2022
ASL Città di Torino

Foddai SG; Cecchi I; Rubini E; Radin M; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.

2022
ASL Città di Torino

Radin M; Arbrile M; Cecchi I; Di Nunzio P; Buccarano N; Di Gregorio F; Milone V; Osella S; Crosasso P; Favuzzi MD; Barinotti A; Baldovino S; Menegatti E; Rossi D; Sciascia S; Roccatello D;

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.

2021
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Rossi D; Mengozzi G; Roccatello D; Bazzan M; Giachino O; Baldovino S; Vaccarino A; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Radin M; Sciascia S;

Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy. in Minerva medica / Minerva Med. 2021 Apr;112(2):162-174. doi: 10.23736/S0026-4806.20.07076-7. Epub 2020 Nov 16.

2021
ASL Città di Torino
AOU Città della Salute di Torino

Barreca A; Solfietti L; Kalikatzaros I; Viziello L; Ventrella F; Kamgaing J; Baldovino S; Ferro M; Fenoglio R; Sciascia S; Rossi D; Roccatello D;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.

2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.

2021
ASL Città di Torino

Arbrile M; Radin M; Rossi D; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.

2020
ASL Città di Torino

Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...

Living with and treating rare diseases: experiences of patients and professional health care providers. in Qualitative health research / Qual Health Res. 2015 May;25(5):636-51. doi: 10.1177/1049732315570116. Epub 2015 Feb 9.

2015
ASL Città di Torino

Garrino L; Picco E; Finiguerra I; Rossi D; Simone P; Roccatello D;

A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment. in Autoimmunity reviews / Autoimmun Rev. 2015 Dec;14(12):1123-30. doi: 10.1016/j.autrev.2015.07.017. Epub 2015 Aug 2.

2015
ASL Città di Torino

Roccatello D; Sciascia S; Baldovino S; Rossi D; Alpa M; Naretto C; Di Simone D; Simoncini M; Menegatti E;

Rheumatoid arthritis: Biological therapy other than anti-TNF. in International immunopharmacology / Int Immunopharmacol. 2015 Aug;27(2):185-8. doi: 10.1016/j.intimp.2015.03.019. Epub 2015 Mar 31.

2015
ASL Città di Torino

Rossi D; Modena V; Sciascia S; Roccatello D;

The role of nail-videocapillaroscopy in early diagnosis of scleroderma. in Autoimmunity reviews / Autoimmun Rev. 2013 Jun;12(8):821-5. doi: 10.1016/j.autrev.2012.11.006. Epub 2012 Dec 4.

2013
ASL Città di Torino

Rossi D; Russo A; Manna E; Binello G; Baldovino S; Sciascia S; Roccatello D;

Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. in Autoimmunity reviews / Autoimmun Rev. 2008 Oct;8(1):56-8. doi: 10.1016/j.autrev.2008.07.027. Epub 2008 Aug 12.

2008
ASL Città di Torino

Alpa M; Ferrero B; Cavallo R; Naretto C; Menegatti E; Di Simone D; Napoli F; La Grotta R; Rossi D; Baldovino S; Sena LM; Roccatello D;

[Antiphospholipid syndrome and kidney]. in Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia / G Ital Nefrol. 2007 Mar-Apr;24(2):111-20.

2007
ASL Città di Torino

Roccatello D; Rossi D; Giachino O; Bazzan M; Mazzucco G;